Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk.

Lokhande, Lavanya; Kuci Emruli, Venera; Kolstad, Arne; Hutchings, Martin; Räty, Riikka; Jerkeman, Mats; Ek, Sara

Lokhande, Lavanya; Kuci Emruli, Venera; Kolstad, Arne; Hutchings, Martin; Räty, Riikka; Jerkeman, Mats; Ek, Sara.

Afiliación

Lokhande L; Department of Immunotechnology, Lund University, Lund, Sweden.
Kuci Emruli V; Department of Immunotechnology, Lund University, Lund, Sweden.
Kolstad A; Oslo University Hospital, Oslo, Norway.
Hutchings M; Department of Haematology, Rigshospitalet, Copenhagen, Denmark.
Räty R; Department of Hematology, Helsinki University Central Hospital, Helsinki, Finland.
Jerkeman M; Department of Oncology, Lund University, Lund, Sweden.
Ek S; Department of Immunotechnology, Lund University, Lund, Sweden. sara.ek@immun.lth.se.

BMC Cancer ; 20(1): 1202, 2020 Dec 07.

Article en En | MEDLINE | ID: mdl-33287742

Asunto(s)

Biomarcadores de Tumor/metabolismo; Linfoma de Células del Manto/inmunología; Anciano; Femenino; Humanos; Masculino; Pronóstico; Medición de Riesgo

Palabras clave

Biomarker discovery; Mantle cell lymphoma (MCL); Protein signature; Serum proteins

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Linfoma de Células del Manto Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google